News | Digital Pathology | March 07, 2024

Digital and computational pathology solution provider Proscia has announced that Pramana, Inc., is now a Proscia Ready partner, in an alliance the companies report paves the way to advance cancer research and diagnosis with enriched, high-quality DICOM images.

Digital and computational pathology solution provider Proscia has announced that Pramana, Inc. is now a Proscia Ready partner, in an alliance the companies report paves the way to advance cancer research and diagnosis with enriched, high-quality DICOM images.

Digital and computational pathology solution provider Proscia has announced that Pramana, Inc. is now a Proscia Ready partner, in an alliance the companies report paves the way to advance cancer research and diagnosis with enriched, high-quality DICOM images. Image courtesy: Proscia


March 7, 2024 — Software company Proscia, a provider of digital and computational pathology solutions, has announced that Pramana, Inc., an AI-enabled health tech company, is now a Proscia Ready partner. Pramana, headquartered in Cambridge, MA, joins the partner alliance to help life sciences organizations and diagnostic laboratories increasingly leverage enriched, high-quality data, including DICOM images, in their routine research and clinical operations, according to a statement released by Philadelphia, PA-based Proscia.

Proscia Ready was established to help laboratories accelerate the scaled adoption of digital pathology with confidence. It delivers on this aim by offering the freedom to choose from established hardware and software solutions; Proscia’s Concentriq enterprise pathology platform is designed to integrate with partners’ technologies and incorporate them into the diverse workflows it drives. Through their partnership, Proscia and Pramana will work to integrate Pramana’s SpectralHT family of scanners with Concentriq, enabling laboratories to benefit from Pramana’s unique approach to whole slide imaging in daily practice.

“Pramana is expanding the potential of pathology data,” said Arun Ananth, Proscia’s Chief Commercial Officer. “It is empowering pathologists and scientists with richer images so that they can make more informed decisions and enabling them to capitalize on the standardization that DICOM provides. We are thrilled to welcome Pramana to Proscia Ready so that customers can increasingly realize these benefits.”

Pramana’s SpectralHT family of scanners provides automatic quality assessment and image enrichment with valuable metadata, all in a standardized DICOM format. The company’s in-line quality assurance module delivers whole slide images with the highest rate of first-pass success while also storing critical information that can help identify areas for improvement in lab practices for sample preparation.

“Our SpectralHT family of scanners continues to gain traction because of the enriched, high-quality images that they create at scale,” said Mike Koenig, Pramana’s Chief Business Officer. “Joining Proscia Ready was an easy decision for us. The partners understand all that laboratories need to maximize the value of this data, paving the way to accelerate research and diagnosis.”

Proscia Ready is an alliance of solution providers helping laboratories to confidently grow their use of digital pathology. As scaling digital pathology adoption requires a broad portfolio of hardware and software solutions, the partners offer a comprehensive approach that enables laboratories to overcome the complexities of working with multiple vendors. This starts with a commitment to interoperability and extends to joint support agreements and a shared vision to guide future innovation.

Proscia is a software company accelerating the transformation to digital pathology, which reports that its Concentriq enterprise pathology platform and powerful AI applications are advancing the 150-year-old standard of research and diagnosis towards a data-driven discipline.

For its part, Pramana, Inc. is a health-tech company founded by nference, inc., enabling seamless digital pathology adoption by pathology labs and medical centers. Built upon extensive industry experience and patented technological innovation, Pramana is a gateway for pathologists and physicians to utilize AI-enabled decision support.

Both companies will be participating in the upcoming United States and Canadian Academy of Pathology 113th Annual Meeting, USCAP 2024, being held March 23-28 in Baltimore, MD.

More information, visit www.proscia.com, www.pramana.ai


Related Content

News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
News | Enterprise Imaging

May 16, 2024 — AGFA HealthCare announced that St. Vincent’s Private Hospital in Dublin, Ireland, has chosen to implement ...

Time May 16, 2024
arrow
News | Artificial Intelligence

May 16, 2024 — deepc, the globally recognized digital medicine pioneer and market leader behind the leading AI operating ...

Time May 16, 2024
arrow
News | Enterprise Imaging

May 15, 2024 — etherFAX announced the expansion of its partnership with Hyland, a leading global provider of intelligent ...

Time May 15, 2024
arrow
News | FDA

May 14, 2024 — Indica Labs, the leading provider of digital pathology solutions, announced today that it received FDA ...

Time May 14, 2024
arrow
News | Cybersecurity

May 13, 2024 — In the wake of the cybersecurity breach targeting the prominent healthcare system Ascension, a new study ...

Time May 13, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | Radiation Oncology

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical ...

Time May 10, 2024
arrow
News | ARRS

May 8, 2024 — Compared to males, women in radiology are at a consistently higher risk of not matching into diagnostic ...

Time May 08, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
Subscribe Now